Gain Therapeutics, Inc.
GANX
$1.72
-$0.11-6.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.46% | 82.35% | 100.63% | -26.91% | -60.47% |
| Total Receivables | -27.05% | 12.18% | 4.82% | 111.02% | 351.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.74% | -42.42% | 32.36% | -30.10% | -7.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 60.85% | 63.40% | 91.66% | -23.46% | -49.80% |
|
|
|||||
| Total Current Assets | 60.85% | 63.40% | 91.66% | -23.46% | -49.80% |
| Net Property, Plant & Equipment | -4.71% | 26.24% | 26.51% | -32.70% | -26.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -39.95% | -28.74% | -23.45% | -26.68% | -19.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.14% | 9.82% | 9.72% | 4.33% | 41.70% |
| Total Assets | 56.82% | 61.20% | 88.22% | -23.63% | -48.77% |
|
|
|||||
| Total Accounts Payable | -55.02% | -29.52% | -12.82% | 43.58% | 32.55% |
| Total Accrued Expenses | -12.09% | -12.31% | -6.59% | -7.12% | -36.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.17% | -17.15% | -18.59% | -18.71% | -11.92% |
| Total Finance Division Other Current Liabilities | 45.51% | -71.71% | -84.08% | -92.10% | -93.69% |
| Total Other Current Liabilities | 45.51% | -71.71% | -84.08% | -92.10% | -93.69% |
| Total Current Liabilities | -33.93% | -22.71% | -14.29% | -9.23% | -20.33% |
|
|
|||||
| Total Current Liabilities | -33.93% | -22.71% | -14.29% | -9.23% | -20.33% |
| Long-Term Debt | -32.36% | -13.10% | -8.59% | -20.55% | -13.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.78% | 495.10% | 294.03% | -32.43% | -30.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -38.93% | -17.29% | -20.48% | 35.65% | 37.99% |
| Total Liabilities | -32.71% | -19.04% | -11.08% | -7.22% | -17.18% |
|
|
|||||
| Common Stock & APIC | 28.83% | 30.94% | 34.20% | 18.67% | 11.73% |
| Retained Earnings | -21.97% | -24.78% | -24.83% | -25.05% | -25.49% |
| Treasury Stock & Other | 71.85% | 931.53% | 413.90% | 131.96% | 4,572.80% |
| Total Common Equity | 205.51% | 142.35% | 152.94% | -33.67% | -68.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 205.51% | 142.35% | 152.94% | -33.67% | -68.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 205.51% | 142.35% | 152.94% | -33.67% | -68.64% |
|
|
|||||